- Home
- UPB vs UVV Comparison
UPB vs UVV Comparison
Compare UPB & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- UVV
- Stock Information
- Founded
- UPB 2021
- UVV 1886
- Country
- UPB United States
- UVV United States
- Employees
- UPB N/A
- UVV N/A
- Industry
- UPB
- UVV Farming/Seeds/Milling
- Sector
- UPB
- UVV Industrials
- Exchange
- UPB NYSE
- UVV Nasdaq
- Market Cap
- UPB 1.3B
- UVV 1.2B
- IPO Year
- UPB 2024
- UVV N/A
- Fundamental
- Price
- UPB $17.80
- UVV $55.68
- Analyst Decision
- UPB Strong Buy
- UVV
- Analyst Count
- UPB 4
- UVV 0
- Target Price
- UPB $56.50
- UVV N/A
- AVG Volume (30 Days)
- UPB 252.2K
- UVV 137.5K
- Earning Date
- UPB 11-07-2024
- UVV 11-29-2024
- Dividend Yield
- UPB N/A
- UVV 5.80%
- EPS Growth
- UPB N/A
- UVV 5.05
- EPS
- UPB N/A
- UVV 4.86
- Revenue
- UPB $2,207,000.00
- UVV $2,827,901,000.00
- Revenue This Year
- UPB N/A
- UVV N/A
- Revenue Next Year
- UPB N/A
- UVV N/A
- P/E Ratio
- UPB N/A
- UVV $11.30
- Revenue Growth
- UPB 82.10
- UVV 6.40
- 52 Week Low
- UPB $17.09
- UVV $45.19
- 52 Week High
- UPB $29.46
- UVV $67.80
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- UVV 66.77
- Support Level
- UPB N/A
- UVV $54.23
- Resistance Level
- UPB N/A
- UVV $55.55
- Average True Range (ATR)
- UPB 0.00
- UVV 1.39
- MACD
- UPB 0.00
- UVV 0.34
- Stochastic Oscillator
- UPB 0.00
- UVV 92.14
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.